Making sense of rapid antigen testing in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics.

Diagnosis
Camilla MattiuzziGiuseppe Lippi

Abstract

Although the most effective strategy for preventing or containing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks relies on early diagnosis, the paramount and unprecedented number of tests needed to fully achieve this target is overwhelming worldwide testing supply and capacity. Molecular detection of SARS-CoV-2 RNA in nasopharyngeal swabs is still considered the reference diagnostic approach. Nonetheless, identification of SARS-CoV-2 proteins in upper respiratory tract specimens and/or saliva by means of rapid (antigen) immunoassays is emerging as a promising screening approach. These tests have some advantages compared to molecular analysis, such as point of care availability, no need of skilled personnel and dedicated instrumentation, lower costs and short turnaround time. However, these advantages are counterbalanced by lower diagnostic sensitivity compared to molecular testing, which would only enable to identifying patients with higher SARS-CoV-2 viral load. The evidence accumulated to-date has hence persuaded us to develop a tentative algorithm, which would magnify the potential benefits of rapid antigen testing in SARS-CoV-2 diagnostics.

References

May 2, 2020·JAMA Internal Medicine·Hao-Yuan ChengUNKNOWN Taiwan COVID-19 Outbreak Investigation Team
May 13, 2020·Annals of Translational Medicine·Giuseppe LippiBrandon M Henry
Jun 5, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Lorena PorteThomas Weitzel
Jun 20, 2020·Nature Medicine·Quan-Xin LongAi-Long Huang
Jun 24, 2020·Proceedings of the National Academy of Sciences of the United States of America·Masaki ImaiYoshihiro Kawaoka
Jul 3, 2020·The Journal of Infection·Kieran A WalshPatricia Harrington
Aug 28, 2020·The Cochrane Database of Systematic Reviews·Jacqueline DinnesUNKNOWN Cochrane COVID-19 Diagnostic Test Accuracy Group
Sep 9, 2020·BMJ : British Medical Journal·Gareth Iacobucci
Sep 11, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Shuai ZhangYang Jin
Sep 18, 2020·Nature·Giorgia Guglielmi
Sep 26, 2020·The American Journal of Nursing·Betsy Todd
Sep 27, 2020·BMJ : British Medical Journal·Jacqui Thornton
Sep 27, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Flora Marzia LiottiBrunella Posteraro
Oct 1, 2020·The New England Journal of Medicine·Michael J MinaDaniel B Larremore
Oct 30, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Giuseppe LippiFabian Sanchis-Gomar
Nov 2, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Aminah NalumansiPontiano Kaleebu
Nov 2, 2020·Indoor Air·Hua QianYuguo Li

❮ Previous
Next ❯

Citations

Feb 9, 2021·Diagnosis·Gian Luca SalvagnoGiuseppe Lippi
Apr 20, 2021·Diagnosis·Giuseppe LippiBrandon M Henry
Apr 29, 2021·Clinical Chemistry and Laboratory Medicine : CCLM·Mary Kathryn BohnUNKNOWN IFCC Taskforce on COVID-19

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.